M. Bowling

发表

A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule 1

L. Grochow, D. Noe, M. Carducci, 2001 .

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.

L. Grochow, D. Ettinger, R. Donehower, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors.

L. Grochow, R. Donehower, S. Kaufmann, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.

L. Grochow, D. Noe, R. Donehower, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.

L. Grochow, M. Carducci, J. Gilbert, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision

D. Goldgar, G. Bowen, J. M. Donigan, 2018, JAMA dermatology.

A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.

L. Grochow, D. Noe, M. Carducci, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies 1

L. Grochow, M. Carducci, J. Gilbert, 2001 .

A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia.

R. Donehower, S. Baker, S. Kaufmann, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent.

L. Grochow, D. Noe, R. Donehower, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer.

D. Ettinger, E. Rowinsky, S. Sartorius, 1995, Seminars in oncology.

Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia

R. Donehower, W. Slichenmyer, E. Rowinsky, 1995, Cancer Chemotherapy and Pharmacology.

A phase I study of diethylnorspermine (DENSPM) in previously treated patients with metastatic breast cancer (MBC)

A. Wolff, N. Davidson, D. Armstrong, 2001 .